Skip to main content
Clinical Trials/NCT02954809
NCT02954809
Completed
Not Applicable

Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

State University of New York at Buffalo1 site in 1 country14 target enrollmentOctober 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fatigue
Sponsor
State University of New York at Buffalo
Enrollment
14
Locations
1
Primary Endpoint
Study Completion
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Detailed Description

A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
January 2018
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carleara Weiss

Principal Investigator

State University of New York at Buffalo

Eligibility Criteria

Inclusion Criteria

  • Stage I-III Non-small cell lung cancer survivors
  • Must be at \>6-weeks and \< 3 years post-surgical resection
  • Must have diagnosis fatigue and/or sleep disturbances

Exclusion Criteria

  • Individuals clinically unstable.
  • Mania, Bipolar disease or seizure disorder
  • Macular degeneration or glaucoma.
  • Currently receiving chemotherapy or radiation.

Outcomes

Primary Outcomes

Study Completion

Time Frame: Baseline

The percentage of participants recruited that completed the study

Study Sites (1)

Loading locations...

Similar Trials